You should know that you are questioning the wrong audience. It's not the FDA's responsibility to make public shareholders aware of what's going on with their investment, it's Prana Biotech's. Apparently they're not ready to talk.
You should know that you are questioning the wrong audience....
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 122248 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 25307592 | 14 |
View Market Depth
| Last trade - 16.12pm 16/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |
Day chart unavailable